Vext Science, Inc.
VEXT
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 21.13% | 10.96% | -8.27% | -7.91% | 2.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.13% | 10.96% | -8.27% | -7.91% | 2.87% |
| Cost of Revenue | 23.02% | -5.21% | 5.45% | 60.04% | 70.56% |
| Gross Profit | 14.50% | 41.49% | -41.79% | -71.63% | -57.03% |
| SG&A Expenses | -62.14% | 11.65% | 234.65% | -8.05% | 260.61% |
| Depreciation & Amortization | 7.92% | 22.83% | 110.62% | 83.40% | 53.52% |
| Other Operating Expenses | 37,500.00% | -- | -- | -- | -- |
| Total Operating Expenses | -16.25% | 4.71% | 43.31% | 40.24% | 121.96% |
| Operating Income | 57.34% | 24.79% | -650.34% | -494.79% | -914.59% |
| Income Before Tax | -190.63% | 5.75% | -645.92% | -524.90% | 9,725.37% |
| Income Tax Expenses | -12.60% | 77.56% | 88.85% | 70.16% | 137.21% |
| Earnings from Continuing Operations | -263.73% | -35.83% | -919.79% | -8,764.02% | -10.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -263.73% | -35.83% | -919.79% | -8,764.02% | -10.53% |
| EBIT | 57.34% | 24.79% | -650.34% | -494.79% | -914.59% |
| EBITDA | 107.94% | 270.80% | -101.98% | -92.52% | -271.70% |
| EPS Basic | -238.29% | 17.07% | -597.22% | -5,720.00% | -39.69% |
| Normalized Basic EPS | 2.62% | 52.63% | -360.00% | -821.43% | -1,691.67% |
| EPS Diluted | -238.29% | 17.07% | -597.22% | -6,100.00% | -39.69% |
| Normalized Diluted EPS | 2.11% | 53.51% | -360.00% | -821.43% | -1,683.33% |
| Average Basic Shares Outstanding | 18.32% | 63.95% | 63.93% | 50.57% | 48.41% |
| Average Diluted Shares Outstanding | 17.75% | 66.03% | 63.53% | 50.50% | 49.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |